These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11378378)

  • 81. NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.
    Hajduk PJ; Shuker SB; Nettesheim DG; Craig R; Augeri DJ; Betebenner D; Albert DH; Guo Y; Meadows RP; Xu L; Michaelides M; Davidsen SK; Fesik SW
    J Med Chem; 2002 Dec; 45(26):5628-39. PubMed ID: 12477346
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Matrix metalloproteinase inhibition of pancreatic cancer: matching mechanism of action to clinical trial design.
    Hess KR; Abbruzzese JL
    J Clin Oncol; 2001 Aug; 19(15):3445-6. PubMed ID: 11481348
    [No Abstract]   [Full Text] [Related]  

  • 83. Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.
    Pratt LM; Beckett RP; Davies SJ; Launchbury SB; Miller A; Spavold ZM; Todd RS; Whittaker M
    Bioorg Med Chem Lett; 2001 Oct; 11(19):2585-8. PubMed ID: 11551755
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).
    Ott GR; Asakawa N; Lu Z; Liu RQ; Covington MB; Vaddi K; Qian M; Newton RC; Christ DD; Traskos JM; Decicco CP; Duan JJ
    Bioorg Med Chem Lett; 2008 Jan; 18(2):694-9. PubMed ID: 18061445
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.
    Krumme D; Tschesche H
    Bioorg Med Chem Lett; 2002 Mar; 12(6):933-6. PubMed ID: 11958997
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Molecule of the month. Vorinostat.
    Drug News Perspect; 2006; 19(6):352. PubMed ID: 16971971
    [No Abstract]   [Full Text] [Related]  

  • 87. Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor: application of film in situ zymography.
    Ikeda M; Maekawa R; Tanaka H; Matsumoto M; Takeda Y; Tamura Y; Nemori R; Yoshioka T
    Clin Cancer Res; 2000 Aug; 6(8):3290-6. PubMed ID: 10955815
    [TBL] [Abstract][Full Text] [Related]  

  • 88. N-substituted homopiperazine barbiturates as gelatinase inhibitors.
    Wang J; Medina C; Radomski MW; Gilmer JF
    Bioorg Med Chem; 2011 Aug; 19(16):4985-99. PubMed ID: 21764590
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Omega-alkoxy analogues of SAHA (vorinostat) as inhibitors of HDAC: a study of chain-length and stereochemical dependence.
    Hanessian S; Auzzas L; Giannini G; Marzi M; Cabri W; Barbarino M; Vesci L; Pisano C
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6261-5. PubMed ID: 17892933
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Towards third generation matrix metalloproteinase inhibitors for cancer therapy.
    Overall CM; Kleifeld O
    Br J Cancer; 2006 Apr; 94(7):941-6. PubMed ID: 16538215
    [TBL] [Abstract][Full Text] [Related]  

  • 91. N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824).
    Remiszewski SW; Sambucetti LC; Bair KW; Bontempo J; Cesarz D; Chandramouli N; Chen R; Cheung M; Cornell-Kennon S; Dean K; Diamantidis G; France D; Green MA; Howell KL; Kashi R; Kwon P; Lassota P; Martin MS; Mou Y; Perez LB; Sharma S; Smith T; Sorensen E; Taplin F; Trogani N; Versace R; Walker H; Weltchek-Engler S; Wood A; Wu A; Atadja P
    J Med Chem; 2003 Oct; 46(21):4609-24. PubMed ID: 14521422
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Role of extracellular matrix degradation enzyme for glioma invasion].
    Nakada M
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():55-60. PubMed ID: 16201500
    [No Abstract]   [Full Text] [Related]  

  • 93. A hydroxamic-acid-containing nucleoside inhibits DNA repair nuclease SNM1A.
    Doherty W; Dürr EM; Baddock HT; Lee SY; McHugh PJ; Brown T; Senge MO; Scanlan EM; McGouran JF
    Org Biomol Chem; 2019 Sep; 17(35):8094-8105. PubMed ID: 31380542
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
    Antczak C; Shum D; Bassit B; Frattini MG; Li Y; de Stanchina E; Scheinberg DA; Djaballah H
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4528-32. PubMed ID: 21719286
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Marimastat (BB2516): current status of development.
    Steward WP
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S56-60. PubMed ID: 10357560
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Synthesis and PDF inhibitory activities of novel benzothiazolylidenehydroxamic acid derivatives.
    Takayama W; Shirasaki Y; Sakai Y; Nakajima E; Fujita S; Sakamoto-Mizutani K; Inoue J
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3273-6. PubMed ID: 12951107
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Matrix metalloproteinase inhibitors in rheumatic diseases.
    Close DR
    Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii62-7. PubMed ID: 11890658
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.
    Robinson RP; Laird ER; Donahue KM; Lopresti-Morrow LL; Mitchell PG; Reese MR; Reeves LM; Rouch AI; Stam EJ; Yocum SA
    Bioorg Med Chem Lett; 2001 May; 11(9):1211-3. PubMed ID: 11354379
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Preparation and fungicidal properties of some arylthioalkanoyl- and (arylsulphonyl)-aceto-hydroxamic acids.
    Zayed SM; Mostafa IY; Farghaly M
    Z Naturforsch B; 1966 Feb; 21(2):180-2. PubMed ID: 4383182
    [No Abstract]   [Full Text] [Related]  

  • 100. Discovery of Potent, Selective, and Direct Acid Sphingomyelinase Inhibitors with Antidepressant Activity.
    Yang K; Yu J; Nong K; Wang Y; Niu A; Chen W; Dong J; Wang J
    J Med Chem; 2020 Feb; 63(3):961-974. PubMed ID: 31944697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.